Gene: TIGAR
Official Full Name: TP53 induced glycolysis regulatory phosphataseprovided by HGNC
Gene Summary: This gene is regulated as part of the p53 tumor suppressor pathway and encodes a protein with sequence similarity to the bisphosphate domain of the glycolytic enzyme that degrades fructose-2,6-bisphosphate. The protein functions by blocking glycolysis and directing the pathway into the pentose phosphate shunt. Expression of this protein also protects cells from DNA damaging reactive oxygen species and provides some protection from DNA damage-induced apoptosis. The 12p13.32 region that includes this gene is paralogous to the 11q13.3 region. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20985 | TIGAR Knockout cell line (HeLa) | Human | TIGAR | 1:3~1:6 | Negative | Online Inquiry |
KO20986 | TIGAR Knockout cell line (HCT 116) | Human | TIGAR | 1:2~1:4 | Negative | Online Inquiry |
KO20987 | TIGAR Knockout cell line (HEK293) | Human | TIGAR | 1:3~1:6 | Negative | Online Inquiry |
KO20988 | TIGAR Knockout cell line (A549) | Human | TIGAR | 1:3~1:4 | Negative | Online Inquiry |
TIGAR Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the detailed study of the TIGAR (TP53-Induced Glycolysis and Apoptosis Regulator) gene's role in cellular metabolism, apoptosis, and cancer biology. These cell lines are meticulously created through targeted gene editing techniques such as CRISPR-Cas9, resulting in a precise knockout of the TIGAR gene while ensuring the integrity of other genomic regions remains intact.
The primary function of the TIGAR Gene Knockout Cell Lines lies in their ability to elucidate the gene's involvement in regulating the metabolic switch between aerobic glycolysis and oxidative phosphorylation. By examining the impact of TIGAR loss on cellular bioenergetics and apoptosis pathways, researchers can uncover critical insights into tumorigenesis and therapeutic resistance, which are of significant interest in cancer research.
From a scientific standpoint, these cell lines serve as invaluable models for advancing our understanding of metabolic regulation in health and disease. Their applications extend to drug discovery, genetic studies, and the development of novel therapeutic strategies aimed at targeting metabolic pathways in cancer cells.
What sets TIGAR Gene Knockout Cell Lines apart from alternatives is their stringent validation for specificity and functionality, along with user-friendly protocols that enhance laboratory efficiency. Unlike transient knockdown methods, these stable cell lines offer consistency and reproducibility in experimental outcomes, making them superior tools for longitudinal studies.
For researchers, clinicians, and pharmaceutical developers, the ability to study TIGAR's role comprehensively through these knockout models translates into actionable knowledge that can guide innovative therapeutic approaches.
Our expertise at [Company Name] in the development of robust, reliable research tools positions us as a leader in the field of genetic engineering and cellular biology, empowering scientists to push the boundaries of knowledge and discovery with precision-driven solutions like TIGAR Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.